Company profile
Winthrop Hall is a purpose built residential drug and alcohol
treatment centre run by Success in Recovery Ltd (SIR).
SIR was founded in 2005 to deliver ground breaking treatment for
drug and alcohol addiction and its goal is to establish a centre of
excellence in this field, offering discreet, private residential
treatment and follow-up.
Jon Moulton is the majority shareholder in SIR and has funded
the building of Winthrop Hall. Jon Moulton is Managing Partner of
Alchemy, a UK-based private equity firm, which has invested £1.8
billion of equity with an emphasis on dealing with troubled
companies. It recently completed the raising of a £300m European
special opportunities fund.
Jon is a Chartered Accountant, a CF and Fellow of the Society of
Turnaround Professionals. He previously worked with Citicorp
Venture Capital in New York and London, Permira and Apax. He has
been a director of five public companies, numerous private
companies and is currently a director of the US-based Irvin
parachute business, the Cedar IT business, Sylvan (timber) and
Ashmore Group – a major investor in emerging market debt.
Lesley Reardon is a director of SIR and the Chief Executive
Officer of Winthrop Hall and has spent all her professional
working life in the healthcare sector. She has worked for the NHS
and for the last 15 years as a senior manager in the independent
sector. Her knowledge spans both the medical/surgical and
psychiatric fields with particular experience in operational
management, human resources, the management of risk and new
business development.
Winthrop Hall is fully registered with CSCI (the Commission for
Social Care Inspection), Lesley Reardon is the Responsible
Individual for registration purposes.